AllAnalyst Report
logoMorningstarNovember 24, 2020

Agilent Technologies, Inc.: Agilent Delivers Strong End to Fiscal 2020, but Management Stays Conservative on Outlook

Symbols
A
Sector(s)
Healthcare
Rating
Premium
Current Price
$126.93
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE